https://deubiquitinase.com/dut....afabs-are-designed-h
All rights reserved.BACKGROUND Merkel cellular carcinoma (MCC) is an aggressive, high-grade, cutaneous neuroendocrine tumour (NET). PD-1/PD-L1 preventing agents have efficacy in metastatic MCC (mMCC), but 50 % of patients usually do not derive durable advantage. Somatostatin analogues (SSA) are generally used to treat reasonable- and moderate-grade NETs that express somatostatin receptors (SSTR). OBJECTIVES To assess SSTR phrase and efficacy of SSA in mMCC, a high-grade NET. TECHNIQUES In this retrospecti
Like
Comment
Share
